PH receives 582,500 doses of AstraZeneca vaccine | Inquirer News

PH receives 582,500 doses of AstraZeneca vaccine

By: - Reporter / @KAguilarINQ
/ 09:50 AM August 20, 2021

astrazeneca vaccine

FILE PHOTO: A medical worker prepares a dose of Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination center in Antwerp, Belgium March 18, 2021. REUTERS/Yves Herman/File Photo

MANILA, Philippines — Some 582,500 AstraZeneca COVID-19 vaccine doses were delivered to the Philippines on Friday.

The vaccines arrived past 9:25 a.m. at the Ninoy Aquino International Airport Terminal 1 onboard a China Airlines flight.

Article continues after this advertisement

The vaccine doses were procured by the private sector and local government units via a tripartite agreement with the national government.

FEATURED STORIES

Last week, 575,800 doses of AstraZeneca jabs ordered by the private sector were also delivered to the country.

In total, the Philippines already received more than 46 million COVID-19 vaccine doses since February.

Article continues after this advertisement

Over 12.8 million individuals have also been fully vaccinated against COVID-19 as of August 18, with nearly 30 million doses already administered.

Article continues after this advertisement

The country is also expecting on Friday the arrival of 739,200 Sinopharm COVID-19 vaccine doses donated by the Chinese government.

READ: About 6 million doses of COVID-19 vaccines arriving this week

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: AstraZeneca, coronavirus Philippines, Vaccines

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.